| Maurissen, Isabelle |
SAUNA, NCT05701241: Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients |
|
|
| Recruiting | 4 | 270 | Europe | Somatostatin analog, lanreotide, octreotide, sandostatin, somatuline | University Hospital, Antwerp, Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Belgium Health Care Knowledge Centre | Gastroenteropancreatic Neuroendocrine Tumor | 04/29 | 04/34 | | |
| Active, not recruiting | 3 | 148 | Europe | acetylsalicylic acid, Placebo | University Hospital, Antwerp, Kom Op Tegen Kanker, Anticancerfund | Colon Cancer | 12/27 | 12/27 | | |
BE-FORCE, NCT06541080: Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the Consortium |
|
|
| Recruiting | N/A | 550 | Europe | Shallow Whole Genome Sequencing (sWGS)-GIPXplore, methylation-sensitive restriction enzymes (MSRE)-Single-molecule molecular inversion probes (smMIP)-seq assay | University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Universiteit Antwerpen, KU Leuven | Neuroendocrine Neoplasms | 12/28 | 12/30 | | |
NCT04735900: lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients |
|
|
| Recruiting | N/A | 60 | Europe | Liquid biopsy sampling | University Hospital, Antwerp, Amgen | Metastatic Colorectal Cancer | 03/22 | 03/22 | | |
Quali-NET, NCT05268783: Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk |
|
|
| Recruiting | N/A | 1000 | Europe | EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey | University Hospital, Antwerp | Quality of Life | 12/29 | 12/29 | | |
